Home Pfizer May Cause Researchers Short-Term Pain, Long-Term Gain
 

Keywords :   


Pfizer May Cause Researchers Short-Term Pain, Long-Term Gain

2015-11-27 21:21:48| Biotech - Topix.net

The marriage of two of the biggest U.S. drugmakers is not without consequences for the rest of the health-care supply chain, particularly for the firms that handle their outsourced research and development work. Pfizer Inc. and Allergan Plc agreed Monday to a $160 billion deal that gives Pfizer a suite of new therapeutic development areas like eye care, women's health and antibiotics.

Tags: gain pain researchers pfizer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »